Meta-analysis of matrix metalloproteinase (MMP)-9 C1562T polymorphism and susceptibility to ischemic stroke in the Chinese population

J Int Med Res. 2020 Jun;48(6):300060520926427. doi: 10.1177/0300060520926427.

Abstract

Objective: Many studies have shown that the C1562T polymorphism in the matrix metalloproteinase (MMP)-9 gene promoter is associated with susceptibility to ischemic stroke (IS), but the association between them remains controversial. Our objective was to explore the relationship between MMP9 C1562T polymorphism and susceptibility to IS in the Chinese population.

Methods: We conducted a database search of Wanfang, China Science and Technology Journal database, China National Knowledge Infrastructure, Medline, Embase, PubMed and Springerlink through September 2019. Meta-analysis was performed using Stata15.0 software (StataCorp LP, College Station, TX, USA).

Results: Thirteen articles were included, including 3,996 patients and 3,815 controls. Among the Chinese population, the results showed no significant difference for the allele model (T vs. C; odds ratio = 1.05, 95%CI: 0.80-1.37). Significant differences were found in the dominant model (TT+TC vs. CC; odds ratio = 2.94, 95%CI: 1.58-5.45) and in the recessive model (TT vs. TC+CC; pooled OR = 0.81, 95%CI: 0.66-0.99). Neither the homozygous model or heterozygous model was significant.

Conclusion: We identified a correlation between MMP-9 C1562T polymorphism and IS in the Chinese population; the TT+TC genotype may increase the risk of IS.

Keywords: Ischemic stroke; MMP-9; dominant model; matrix metalloproteinase-9; meta-analysis; polymorphism.

Publication types

  • Meta-Analysis

MeSH terms

  • Alleles
  • Asian People / genetics
  • China / epidemiology
  • Genetic Predisposition to Disease*
  • Heterozygote
  • Homozygote
  • Humans
  • Ischemic Stroke / epidemiology
  • Ischemic Stroke / genetics*
  • Matrix Metalloproteinase 9 / genetics*
  • Polymorphism, Single Nucleotide
  • Risk Factors

Substances

  • MMP9 protein, human
  • Matrix Metalloproteinase 9